Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

Sipuleucel-T is an autologous cellular immunotherapy approved in the US for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). This significant advance for mCRPC treatment provides healthcare professionals with another effective therapy to ex...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Gulley, James L., Mulders, Peter, Albers, Peter, Banchereau, Jacques, Bolla, Michel, Pantel, Klaus, Powles, Thomas
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2015
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839373/
https://ncbi.nlm.nih.gov/pubmed/27141392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1107698
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi